Literature DB >> 11795389

Estrogen-associated genes in uterine leiomyoma.

S Li1, J A McLachlan.   

Abstract

Uterine leiomyomas or fibroids are classified as a benign uterine disease in that the polyps display no malignant growth. However, uterine leiomyomas are a leading cause of morbidity, infertility, and hysterectomy in women. Since leiomyomas are known to be sensitive to estrogen for their growth, we have examined uterine genes known to be estrogen responsive in affected and unaffected uterine tissue. This information will be useful in determining the contribution, if any, of hormonally active environmental chemicals to this highly prevalent reproductive disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11795389     DOI: 10.1111/j.1749-6632.2001.tb03992.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.

Authors:  Molly B Moravek; Serdar E Bulun
Journal:  Curr Opin Obstet Gynecol       Date:  2015-08       Impact factor: 1.927

2.  Identification of proteins with different abundance associated with cell migration and proliferation in leiomyoma interstitial fluid by proteomics.

Authors:  Blendi Ura; Federica Scrimin; Cinzia Franchin; Giorgio Arrigoni; Danilo Licastro; Lorenzo Monasta; Giuseppe Ricci
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

3.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

4.  Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.

Authors:  Woong Shick Ahn; Ko-Woon Kim; Su Mi Bae; Joo Hee Yoon; Joon Mo Lee; Sung Eun Namkoong; Jin Hong Kim; Chong Kook Kim; Young Joo Lee; Yong-Wan Kim
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

Review 5.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Authors:  Molly B Moravek; Ping Yin; Masanori Ono; John S Coon; Matthew T Dyson; Antonia Navarro; Erica E Marsh; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2014-09-08       Impact factor: 15.610

6.  Cognitive performance in healthy women during induced hypogonadism and ovarian steroid addback.

Authors:  Peter J Schmidt; P A Keenan; Linda A Schenkel; Kate Berlin; Carolyn Gibson; David R Rubinow
Journal:  Arch Womens Ment Health       Date:  2012-11-28       Impact factor: 3.633

7.  Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells.

Authors:  Linda Yu; Alicia B Moore; Lysandra Castro; Xiaohua Gao; Hoang-Long C Huynh; Michelle Klippel; Norris D Flagler; Yi Lu; Grace E Kissling; Darlene Dixon
Journal:  J Signal Transduct       Date:  2012-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.